Lipocine Inc (LPCN) has fallen 17.53% Friday In Premarket Trading

Lipocine Inc (LPCN) has fallen Friday morning, with the stock declining -17.53% in pre-market trading to 4. LPCN's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 95 out of 146 industries, the stock ranks higher than 68% of stocks. Lipocine Inc has risen 1464.52% over the past month, closing at $0.29 on April 14. During this period of time, the stock fell as low as $0.24 and as high as $0.35. LPCN has an average analyst recommendation of Strong Buy. The company has an average price target of $3.67.

LPCN has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on LPCN!

See Full LPCN Report

Lipocine Inc has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 86 by this metric, LPCN ranks better than 86% of stocks.

Important Dates for Investors in LPCN:

-Lipocine Inc is set to release earnings on 5/15/2023. Over the last 12 months, the company has reported EPS of $-0.02. -We do not have a set dividend date for Lipocine Inc at this time. Click Here To Get The Full Report on Lipocine Inc (LPCN)